Thyroiditis

THYROIDITIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_THYROIDITACU E4_THYROIDITSUBAC E4_THYROIDITCHRON E4_THYROIDITAUTOIM E4_THYROIDITDRUG E4_THYROIDITNAS	2826
6. Filter based on genotype QC (FinnGen only)	2826

Control definitions (FinnGen only)

Control exclude: THYROID_DISORDER_IBD

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	THYROIDITIS
CONTROL_EXCLUDE	THYROID_DISORDER_IBD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_THYROIDITACU\|E4_THYROIDITSUBAC\|E4_THYROIDITCHRON\|E4_THYROIDITAUTOIM\|E4_THYROIDITDRUG\|E4_THYROIDITNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Thyroiditis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19571	15459	3979
Only index persons	17896	14316	3580
Unadjusted period prevalence (%)
Whole population	0.37	0.44	0.11
Only index persons	0.45	0.53	0.14
Median age at first event (years)
Whole population	45.67	45.04	48.17
Only index persons	44.76	44.12	47.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2826	2329	497
Unadjusted period prevalence (%)	0.69	0.79	0.22
Median age at first event (years)	45.85	44.88	50.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2521: Matched controls
25208

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

323.0

989

E06.9

ICD-10 Finland

Thyroiditis, unspecified

925.1

323.0

392

H03BB01

ATC

carbimazole; oral

124.6

323.0

363

H03AA01

ATC

levothyroxine sodium; systemic

6.0

323.0

1349

4051

E06.3

ICD-10 Finland

Autoimmune thyroiditis

416.2

323.0

600

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

415.3

266.5

263

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

885.8

249.4

241

104

Kela drug reimbursment

Thyroid insufficiency

6.5

178.3

512

948

E06.0

ICD-10 Finland

Acute thyroiditis

197.8

144.3

149

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

4.2

141.6

633

1869

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

13.8

140.0

250

200

2451A

ICD-9 Finland

Thyroiditis, Subacute thyroiditis

+∞

124.0

118

H02AB06

ATC

prednisolone; systemic

2.6

112.9

1429

8438

24509

ICD-8 Finland

Thyroiditis, Unspecified

+∞

107.0

102

24500

ICD-8 Finland

Thyroiditis, Subacuta de Quervain

+∞

74.3

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

+∞

74.3

E06.4

ICD-10 Finland

Drug-induced thyroiditis

+∞

73.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.5

66.3

253

611

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

50.7

61.5

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

11.1

60.7

118

111

BAA60

NOMESCO Finland

Total thyroidectomy

8.0

60.1

141

185

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

57.5

2459X

ICD-9 Finland

Thyroiditis, unspecified

+∞

56.5

C07AA05

ATC

propranolol; systemic

2.3

55.6

628

3179

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.8

52.7

187

417

2452A

ICD-9 Finland

Thyroiditis, Chronic lymphocytic thyroiditis

+∞

50.2

24503

ICD-8 Finland

Thyroiditis, Chronica

+∞

50.2

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

8.8

47.5

104

122

24501

ICD-8 Finland

Thyroiditis, Subacuta alia

+∞

47.0

E03

ICD-10 Finland

Other hypothyroidism

3.3

45.2

249

816

H02AB07

ATC

prednisone; oral

2.4

44.6

450

2129

A02BC02

ATC

pantoprazole; systemic

1.8

39.3

1631

12849

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

135.4

37.8

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

187.6

35.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

35.7

972

6664

E05.89

ICD-10 Finland

Other thyrotoxicosis

+∞

34.4

E06

ICD-10 Finland

Thyroiditis

42.6

34.1

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

32.0

33.5

H062, E050

ICD-10 Finland

+∞

31.3

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

3.5

30.9

151

450

C07AB07

ATC

bisoprolol; oral

1.7

30.4

1017

7300

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

30.1

643

4036

T86

ICPC

Hypothyroidism/myxoedema

3.2

27.4

149

482

C01BD01

ATC

amiodarone; systemic

5.3

26.8

160

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

6.3

26.2

116

A02BC05

ATC

esomeprazole; systemic

1.6

25.0

993

7334

R53

ICD-10 Finland

Malaise and fatigue

1.8

24.6

526

3273

R07.0

ICD-10 Finland

Pain in throat

2.5

23.9

195

812

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

23.9

941

6917

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

5.0

23.2

157

R50.9

ICD-10 Finland

Fever, unspecified

2.0

23.1

345

1891

T85

ICPC

Hyperthyroidism/thyrotoxicosis

17.4

23.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

23.1

618

4098

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

22.1

790

5642

E03.82

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

24.4

20.8

R51.80

ICD-10 Finland

Headache

1.8

20.8

407

2447

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

211.6

20.6

E06.5

ICD-10 Finland

Other chronic thyroiditis

110.9

20.6

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

4.0

20.3

209

A02BC03

ATC

lansoprazole; oral

1.6

20.2

685

4806

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

20.2

663

4617

R03AC02

ATC

salbutamol; inhalant

1.5

20.0

1295

10500

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

4.5

19.9

161

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

3.7

19.4

244

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

19.2

1084

8513

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.1

19.1

109

366

G44.2

ICD-10 Finland

Tension-type headache

1.8

18.8

365

2185

R00.2

ICD-10 Finland

Palpitations

2.2

17.8

198

960

R21

ICPC

Throat symptom/complaint

1.6

17.7

517

3476

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

17.7

571

3939

R06.0

ICD-10 Finland

Dyspnoea

1.6

17.5

550

3767

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

17.2

566

3918

M54.5

ICD-10 Finland

Low back pain

1.5

16.6

782

5865

N03AX16

ATC

pregabalin; oral

1.6

16.1

550

3831

E03.3

ICD-10 Finland

Postinfectious hypothyroidism

30.2

16.1

J01FA10

ATC

azithromycin; systemic

1.4

16.1

1442

12222

J01DB01

ATC

cefalexin; oral

1.5

16.0

1977

17840

J01AA02

ATC

doxycycline; systemic

1.5

15.6

1864

16638

24409

ICD-8 Finland

Myxoedema, (hypothyreosis) NUD

13.8

15.5

M79.6

ICD-10 Finland

Pain in limb

1.4

15.4

841

6476

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

6.6

15.4

J01DA01

ATC

[U] cefalexin; systemic

1.4

15.2

1493

12803

J01FA06

ATC

roxithromycin; oral

1.4

15.1

957

7576

M79.1

ICD-10 Finland

Myalgia

1.7

14.5

323

2009

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.5

978

7817

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

14.3

405

2683

E03.8

ICD-10 Finland

Other specified hypothyroidism

11.4

14.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

14.2

408

2716

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

14.0

291

1771

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

13.8

388

2566

R52.9

ICD-10 Finland

Pain, unspecified

1.9

13.8

198

1066

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

13.7

138

639

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

13.6

271

1630

UJF32

NOMESCO Finland

Coloscopy

1.5

13.5

545

3924

N02AX02

ATC

tramadol; systemic, rectal

1.4

13.4

910

7252

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.2

392

2630

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.8

13.2

147

N02BE01

ATC

paracetamol; systemic, rectal

1.5

13.1

2062

18977

K30

ICD-10 Finland

Functional dyspepsia

1.8

13.0

253

1508

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

13.0

492

3489

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

5.1

12.9

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.9

12.8

136

R01AD09

ATC

mometasone; nasal

1.4

12.8

1085

8961

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

12.5

373

2503

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

12.3

239

1424

J01MA02

ATC

ciprofloxacin; systemic

1.4

12.1

813

6433

J02AC01

ATC

fluconazole; systemic

1.4

11.9

1069

8872

R51

ICD-10 Finland

Headache

2.1

11.7

131

640

A02BC01

ATC

omeprazole; systemic

1.4

11.7

604

4555

2448A

ICD-9 Finland

Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]

30.2

11.6

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

12.6

11.6

A03

ICPC

Fever

1.6

11.6

367

2492

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

11.4

314

2060

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.3

388

2685

M25.5

ICD-10 Finland

Pain in joint

1.4

11.3

665

5132

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

11.3

532

3938

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

11.2

252

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

11.2

354

2406

N01

ICPC

Headache

1.7

11.1

245

1516

207

Kela drug reimbursment

Chronic arrhythmias

1.7

11.0

229

1392

SPAT1263

SPAT

Sampling

1.3

10.8

962

7936

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

10.8

327

2197

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

10.7

117

565

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

10.5

911

7478

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

+∞

10.4

C07AB02

ATC

metoprolol; systemic

1.5

10.4

377

2640

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

10.3

301

2007

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.1

528

3975

BA1AE

SPAT

4.8

10.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

10.0

358

2498

R06AX27

ATC

desloratadine; oral

1.4

10.0

652

5099

N03AX12

ATC

gabapentin; oral

1.5

10.0

342

2362

L02

ICPC

Back symptom/complaint

1.7

10.0

213

1306

R13

ICD-10 Finland

Dysphagia

1.9

10.0

136

721

R03DC03

ATC

montelukast; oral

1.5

10.0

382

2707

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.0

9.9

119

600

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

6.3

9.8

M03BX02

ATC

tizanidine; oral

1.3

9.7

1449

12812

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

9.7

469

3483

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

9.6

208

1279

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

9.5

538

4103

XQ800

NOMESCO Finland

Prick test

1.7

9.5

187

1119

L01

ICPC

Neck symptom/complaint

1.5

9.4

318

2189

A04

ICPC

Weakness/tiredness general

1.6

9.4

276

1840

R74

ICPC

Upper respiratory infection acute

1.4

9.3

665

5276

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.4

9.3

321

N30.0

ICD-10 Finland

Acute cystitis

1.5

9.2

325

2258

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.2

712

5719

SPAT1097

SPAT

Recording of ECG

1.5

9.1

284

1919

J01CA04

ATC

amoxicillin; systemic

1.3

9.1

1930

17855

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

9.0

177

1059

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

9.0

479

3610

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

9.0

139

770

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

9.0

454

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.9

243

1589

L17

ICPC

Foot/toe symptom/complaint

1.4

8.9

535

4117

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

8.9

169

1002

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.8

8.8

XF404

NOMESCO Finland

Ambulatory ECG

1.7

8.8

179

1082

R06AE07

ATC

cetirizine; oral

1.3

8.8

1036

8820

H04AA01

ATC

glucagon; nasal, parenteral

2.7

8.8

220

J01

ICD-10 Finland

Acute sinusitis

1.9

8.7

115

604

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

8.7

258

1726

L80

ICD-10 Finland

Vitiligo

7.6

8.6

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

11.6

8.6

A02BA02

ATC

ranitidine; systemic

1.4

8.6

392

2874

M54.2

ICD-10 Finland

Cervicalgia

1.8

8.5

157

919

A03FA02

ATC

cisapride; oral, rectal

1.7

8.5

164

974

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

10.1

8.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

8.5

1103

9504

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

8.5

356

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.4

616

4889

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

8.4

1655

15038

TFP35

NOMESCO Finland

Electroanatomical mapping

3.8

8.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

8.4

136

764

I49.1

ICD-10 Finland

Atrial premature depolarization

2.3

8.4

327

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

8.4

252

1688

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.0

8.3

102

519

2458X

ICD-9 Finland

Thyroiditis, Other and unspecified chronic thyroiditis

+∞

8.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

8.3

294

2042

K80

ICPC

Cardiac arrhythmia NOS

1.7

8.3

155

914

H05.2

ICD-10 Finland

Exophthalmic conditions

10.8

8.3

R01AD08

ATC

fluticasone; nasal

1.3

8.3

663

5337

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

8.3

209

1344

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.3

646

5180

R05

ICD-10 Finland

Cough

1.4

8.2

402

2978

SPAT1283

SPAT

Restricted health certificate

1.4

8.2

407

3024

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

8.2

197

1250

J01FA09

ATC

clarithromycin; systemic

1.3

8.2

718

5855

N05CF01

ATC

zopiclone; oral

1.3

8.2

674

5447

R42

ICD-10 Finland

Dizziness and giddiness

1.4

8.1

452

3430

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

8.1

482

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.0

8.1

143

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.0

788

6524

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

8.0

992

8469

C01BC04

ATC

flecainide; systemic

2.4

8.0

276

M01AH05

ATC

etoricoxib; oral

1.3

8.0

1322

11711

D11

ICPC

Diarrhoea

1.5

8.0

243

1634

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

8.0

138

796

H02AB04

ATC

methylprednisolone; systemic

1.5

7.9

310

2203

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.8

884

7456

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

7.8

459

3516

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.9

7.8

102

535

R05

ICPC

Cough

1.4

7.7

482

3727

N06AX21

ATC

duloxetine; oral

1.5

7.7

246

1673

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

4.6

7.7

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

7.4

7.7

A02BC04

ATC

rabeprazole; oral

1.6

7.7

193

1238

L16

ICPC

Ankle symptom/complaint

1.6

7.6

216

1428

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.8

7.6

160

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

7.6

619

4984

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

7.5

102

539

R49.01

ICD-10 Finland

Functional dysphonia

2.2

7.5

337

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

7.5

179

1130

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

7.5

394

UKC02

NOMESCO Finland

Cystoscopy

1.5

7.4

244

1668

H03BA02

ATC

propylthiouracil; oral

80.3

7.4

N06AX11

ATC

mirtazapine; oral

1.3

7.4

691

5667

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

7.4

201

1314

AA1AD

NOMESCO Finland

CT of head and brain

1.4

7.3

429

3279

R03AC03

ATC

terbutaline; inhalant

1.4

7.3

305

2194

2450A

ICD-9 Finland

Thyroiditis, Acute thyroiditis

+∞

7.3

24502

ICD-8 Finland

Thyroiditis, Subchronica

+∞

7.3

TFP34

NOMESCO Finland

Electrophysiological investigation

2.4

7.3

245

XF402

NOMESCO Finland

ECG with work load test

1.6

7.3

197

1290

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.3

210

1393

2504

FHL

Unilateral resection or enucleation

4.5

7.3

R03BA01

ATC

beclometasone; inhalant

1.4

7.2

299

2148

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

3.9

7.2

D10

ICPC

Vomiting

1.7

7.1

129

755

R01AD01

ATC

beclometasone; nasal

1.4

7.1

335

2467

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.0

255

1780

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

7.0

1300

11591

6481B

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]

10.0

7.0

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

10.0

7.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

7.0

213

1432

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.0

7.0

124

C07AA07

ATC

sotalol; systemic

2.3

7.0

269

SPAT1301

SPAT

No procedures

1.3

7.0

652

5346

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

6.9

230

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

6.9

380

2871

A07AA02

ATC

nystatin; oral

1.7

6.9

132

784

A10AA01

ATC

2.3

6.9

271

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

6.9

171

1095

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.9

774

6498

A11

ICPC

Chest pain NOS

1.7

6.9

142

866

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

6.9

207

1389

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

6.8

140

852

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

6.8

104

576

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

6.8

115

658

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.8

704

5847

R52.2

ICD-10 Finland

Other chronic pain

2.1

6.8

369

XKD00

NOMESCO Finland

Uroflowmetry

1.6

6.8

179

1164

K08.80

ICD-10 Finland

Toothache NOS

1.6

6.7

174

1123

J01MA12

ATC

levofloxacin; systemic

1.4

6.7

346

2584

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

6.7

186

1224

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.7

147

912

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

6.7

1237

11001

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

6.6

472

G50.1

ICD-10 Finland

Atypical facial pain

2.5

6.6

187

N76.0

ICD-10 Finland

Acute vaginitis

1.7

6.6

143

884

WX110

NOMESCO Finland

Local anesthesy

1.2

6.6

1579

14448

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

6.6

540

4338

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

6.6

115

667

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.6

1270

11343

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

6.5

287

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.5

1505

13704

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.5

1115

9821

N89

ICPC

Migraine

2.0

6.5

389

A01

ICPC

Pain general/multiple sites

1.6

6.4

160

1026

H3600, E103

ICD-10 Finland

3.4

6.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.4

562

4563

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.5

6.4

186

B01AA03

ATC

warfarin; systemic

1.4

6.4

282

2054

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.2

6.3

C09CA06

ATC

candesartan; oral

1.3

6.3

429

3357

Z00.0

ICD-10 Finland

General medical examination

1.4

6.3

359

2728

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

6.3

121

723

24200

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi

+∞

6.3

24209

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffuse NUD

+∞

6.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

2.9

6.2

117

M02AA07

ATC

piroxicam; topical

1.3

6.2

753

6362

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

6.2

134

826

M01AE02

ATC

naproxen; oral, rectal

1.2

6.2

1289

11571

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

6.2

179

1189

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

6.2

127

771

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

6.2

224

1566

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

6.1

330

2482

Angiography of the heart and coronary arteries

1.9

6.1

414

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

6.1

175

1161

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

6.1

181

1212

2506

FHL

Thyroidectomy

10.0

6.0

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

6.0

125

763

M79.7

ICD-10 Finland

Fibromyalgia

1.9

6.0

469

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

781

1890

5.33

312.80

1.5

1.2

iu/ml

227.3

150.5

4.01

392

694

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

757

1407

6.98

307.65

4.4

2.3

pmol/l

4.6

4.4

2.97

683

1224

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

484

379

15.20

307.65

2.2

1.2

iu/l

3.6

2.7

0.99

195

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2566

19435

4.48

132.12

9.2

4.0

pmol/l

15.4

14.6

36.08

2456

17852

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2641

22532

3.63

69.36

10.4

4.7

mu/l

1.9

2.1

0.85

2521

20873

(3013707) Erythrocyte sedimentation rate by Westergren method

2224

17750

2.19

62.49

5.3

4.0

mm/h

12.6

11.6

2.65

2099

16498

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1523

11101

1.81

50.52

6.8

6.3

mmol/l

1.2

0.21

1307

9419

(3013650) Neutrophils [#/volume] in Blood by Automated count

1781

13711

1.81

48.09

9.0

8.9

e9/l

4.0

0.05

1591

12020

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2157

17913

1.86

41.95

7.8

7.3

u/l

75.2

76.9

0.82

2046

16836

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1362

10008

1.70

40.39

6.2

5.6

mmol/l

1.2

0.26

1239

9070

(3036481) Cortisol [Moles/volume] in Serum or Plasma

432

2248

2.09

39.09

2.2

2.1

nmol/l

384.1

372.7

0.61

395

2056

(3006315) Basophils [#/volume] in Blood

1545

11855

1.67

37.91

6.1

5.8

e9/l

0.0

0.45

1361

10299

(3013115) Eosinophils [#/volume] in Blood

1588

12289

1.67

37.55

6.4

6.0

e9/l

0.2

0.42

1426

10861

(3019198) Lymphocytes [#/volume] in Blood

1576

12179

1.66

37.41

6.2

5.8

e9/l

2.0

1.9

0.38

1428

10810

(3001604) Monocytes [#/volume] in Blood

1538

11813

1.66

37.37

6.1

5.8

e9/l

0.6

0.05

1353

10274

(3013826) Glucose [Moles/volume] in Serum or Plasma

1675

13188

1.66

36.62

4.9

4.4

mmol/l

6.6

0.06

1587

12221

(3018418) pH of Serum or Plasma

960

6607

1.69

35.05

3.9

3.8

7.4

0.12

167

1239

(3022096) Basophils/100 leukocytes in Blood

1400

10745

1.60

32.16

6.4

5.9

0.7

0.33

1298

10019

(3019069) Monocytes/100 leukocytes in Blood

1441

11158

1.59

31.72

6.7

6.1

8.4

8.3

0.48

1347

10463

(3002030) Lymphocytes/100 leukocytes in Blood

1477

11512

1.59

31.55

6.4

5.9

29.3

28.7

1.20

1375

10749

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

946

6636

1.64

31.26

2.3

2.1

u/l

122.3

189.5

3.58

896

6256

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

250

3.85

31.08

2.6

4.6

u/ml

162.9

78.3

0.45

(3006504) Eosinophils/100 leukocytes in Blood

1430

11088

1.59

31.03

6.4

5.9

2.8

0.07

1322

10323

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1339

10227

1.59

30.98

2.5

2.3

nmol/l

78.5

77.4

0.78

1231

9298

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

702

4566

1.72

30.92

1.3

iu/ml

26.6

31.1

0.48

222

1458

(3018010) Neutrophils/100 leukocytes in Blood

1456

11350

1.58

30.78

6.3

5.7

56.2

56.8

1.06

1361

10623

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1516

11935

1.58

30.66

5.7

6.0

umol/l

9.8

10.6

3.65

1441

11298

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2626

23983

2.34

30.40

16.8

12.8

mg/l

19.2

21.4

3.30

2238

18751

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

838

5790

1.64

28.97

1.4

1.3

u/ml

1.9

1.5

0.27

227

1564

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1094

8093

1.57

28.24

3.8

3.3

ng/l

28.2

38.3

0.83

658

4996

(3037522) Nuclear Ab [Titer] in Serum

557

3488

1.74

27.76

1.5

1.3

titre

527.7

577.9

0.24

140

737

(3015377) Calcium [Moles/volume] in Serum or Plasma

1065

7904

1.56

26.69

3.0

3.3

mmol/l

2.3

2.4

1.89

923

6967

(42870588) Differential panel, method unspecified - Blood

1053

7799

1.56

26.61

6.4

5.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2628

24224

2.21

26.10

17.5

14.1

mmol/l

139.6

139.7

1.20

2591

23595

(3007164) IgA [Mass/volume] in Serum or Plasma

728

4963

1.63

26.09

1.5

1.4

g/l

2.1

2.3

1.55

433

3028

(3023103) Potassium [Moles/volume] in Serum or Plasma

2631

24299

2.20

25.38

17.6

14.2

mmol/l

3.9

0.15

2587

23620

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1406

11178

1.51

25.11

3.4

2.8

ug/l

109.3

97.1

0.92

1298

10437

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

737

5106

1.60

24.46

1.9

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

982

7264

1.54

24.43

2.6

2.5

u/l

55.0

57.2

1.06

912

6708

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

765

5372

1.58

23.88

1.8

1.7

mg/l

0.8

1.1

2.71

569

4068

(3024561) Albumin [Mass/volume] in Serum or Plasma

1238

9680

1.50

23.36

4.2

4.6

g/l

36.1

35.9

0.57

1141

8987

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

787

5609

1.56

22.85

3.2

2.8

ng/l

1045.4

1142.5

0.31

671

4718

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

145

600

2.49

22.40

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

639

4374

1.60

21.97

1.4

1.3

u/ml

7.9

11.1

0.89

268

1735

(3032080) INR in Blood by Coagulation assay

1085

8432

1.47

20.21

8.2

7.8

inr

1.2

0.03

338

2501

(3037467) Urinalysis macro (dipstick) panel - Urine

1909

16550

1.47

19.67

4.9

4.3

—

(3015736) pH of Urine

1157

9139

1.45

19.62

3.7

3.4

—

5.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

751

5448

1.52

19.57

3.9

4.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

273

1543

1.85

18.79

2.5

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

516

3475

1.59

18.67

3.4

3.5

mmol/l

0.8

1.92

482

3242

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2674

25225

2.12

18.35

18.1

14.6

umol/l

72.4

71.5

0.92

2674

25218

(3035350) Ketones [Presence] in Urine by Test strip

1424

11787

1.42

18.17

4.0

3.6

estimate

0.0

0.50

241

2171

(3009261) Glucose [Presence] in Urine by Test strip

1442

11963

1.42

18.17

4.0

3.7

estimate

0.0

1.08

242

2174

(3031040) Bacteria [#/volume] in Urine by Automated count

1837

15957

1.43

17.59

5.0

4.4

e6/l

2194.5

2435.9

0.06

198

(3044889) 12 lead EKG panel

1849

16092

1.43

17.43

4.0

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1423

11842

1.41

17.25

5.3

4.9

estimate

0.0

0.80

241

2209

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

286

1686

1.77

17.09

3.1

3.6

ng/l

77.7

83.4

0.56

247

1444

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2677

25359

2.06

16.63

12.0

9.9

u/l

24.6

24.8

0.21

2609

24520

(3024980) IgG subclass 4 [Mass/volume] in Serum

373

2.60

16.42

1.5

1.6

g/l

0.7

0.8

0.09

284

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

163

813

2.07

16.15

1.9

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

195

1040

1.94

16.00

1.3

u/ml

0.8

1.7

0.68

(3005719) IgG [Mass/volume] in Serum or Plasma

292

1765

1.73

15.96

2.6

2.8

g/l

10.4

0.05

264

1610

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

574

4094

1.50

15.75

4.4

3.4

ng/l

112.5

378.3

3.82

374

2874

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

766

5807

1.44

15.31

2.4

2.2

mg/l

2.7

2.9

2.28

656

4955

(40758558) Short blood count panel - Blood

789

6020

1.43

15.21

6.9

6.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2324

21319

1.51

15.08

6.0

5.3

mmol/mol

39.4

39.0

1.16

2177

19855

(3017143) Hepatitis C virus Ab [Presence] in Serum

430

2917

1.56

14.80

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

688

5148

1.44

14.66

4.3

4.0

kg/l

1.0

1.00

734

(40761511) CBC panel - Blood by Automated count

2644

25065

1.85

14.53

15.4

12.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

130

620

2.15

14.50

2.3

2.0

mg/l

11.0

11.3

0.17

121

576

(3048689) Calprotectin [Mass/mass] in Stool

457

3166

1.53

14.27

2.1

2.3

ug/g

99.5

114.5

0.43

342

2465

(3021589) Normoblasts [#/volume] in Blood

1267

10551

1.36

14.24

9.8

8.9

e9/l

0.0

0.45

1037

8628

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

184

1002

1.89

14.19

2.2

1.9

u/l

37.1

39.5

0.97

170

908

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

639

4754

1.44

13.94

1.6

pmol/l

16179785.5

36074638.0

0.55

513

3989

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

972

7807

1.37

13.53

3.4

3.2

u/l

29.5

31.1

0.80

936

7430

(3022948) Iron [Moles/volume] in Serum or Plasma

481

3406

1.50

13.47

2.5

2.3

umol/l

13.5

13.4

0.02

439

3148

(3018095) Leukocytes [#/volume] in Urine

1002

8093

1.37

13.45

3.8

3.5

e6/l

69.3

86.7

0.51

722

5494

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1110

9111

1.36

13.44

4.1

3.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

277

1730

1.67

13.36

2.5

2.4

au/ml

14.5

25.6

1.54

104

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

257

1580

1.69

13.16

1.3

au/ml

42.1

44.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

232

1389

1.73

13.08

1.8

g/l

1.3

1.4

0.43

210

1270

(3004789) Transferrin [Mass/volume] in Serum or Plasma

441

3090

1.51

12.96

2.5

2.3

g/l

2.4

0.57

400

2864

(3026008) Bacteria identified in Urine by Culture

922

7408

1.36

12.59

3.1

3.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

562

4153

1.44

12.57

2.7

2.9

mmol/l

2.4

2.75

486

3648

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2452

22940

1.52

12.54

4.7

4.3

mmol/l

5.8

0.18

2278

21090

(3009445) Proteinase 3 Ab [Units/volume] in Serum

165

904

1.88

12.50

1.5

u/ml

15.2

10.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

147

777

1.94

12.42

1.9

1.8

g/l

0.2

0.68

140

732

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1101

9118

1.34

12.23

2.1

1.9

pmol/l

98.2

97.5

0.19

564

4573

(3002582) Erythrocytes [#/volume] in Urine

837

6676

1.36

11.82

3.1

e6/l

76.8

83.1

0.07

659

5053

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

141

748

1.93

11.79

1.4

1.3

u/ml

7.8

37.1

1.92

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

149

808

1.89

11.67

1.8

1.7

g/l

1.2

0.07

142

765

(3003458) Phosphate [Moles/volume] in Serum or Plasma

388

2703

1.50

11.66

4.8

5.7

mmol/l

1.0

0.61

367

2505

(3029937) Albumin [Presence] in Urine by Test strip

795

6310

1.36

11.53

4.4

4.0

estimate

0.0

1.28

241

2186

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

405

2853

1.49

11.52

2.6

2.4

22.8

22.9

0.01

327

2442

(3020630) Protein [Mass/volume] in Serum or Plasma

260

1659

1.62

11.50

2.4

2.7

g/l

67.3

66.8

0.57

236

1514

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

115

574

2.05

11.44

1.3

1.2

u/ml

35.8

41.9

0.16

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

466

3380

1.45

11.41

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2394

22391

1.45

11.24

14.1

11.7

ml/min/173m2

83.7

83.6

0.05

2041

18316

(3023368) Bacteria identified in Blood by Culture

699

5466

1.37

11.07

4.6

4.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

220

1364

1.66

10.90

2.1

2.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

329

2248

1.52

10.81

3.7

4.1

u/l

231.2

247.3

1.23

312

2125

(3048929) Epstein Barr virus Ab [Presence] in Serum

143

787

1.86

10.72

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

155

3.00

10.69

4.1

6.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

285

1893

1.56

10.64

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

236

2.58

10.45

1.5

g/l

0.3

0.4

3.58

166

(3028192) IgG subclass 2 [Mass/volume] in Serum

236

2.58

10.45

1.5

g/l

2.8

2.9

0.17

166

(3027135) IgG subclass 1 [Mass/volume] in Serum

237

2.56

10.36

1.5

g/l

6.4

6.9

0.56

167

(3000850) Epithelial cells [#/volume] in Urine

602

4646

1.38

10.25

2.4

2.5

e6/l

6.7

7.1

0.18

527

4045

(3022217) INR in Platelet poor plasma by Coagulation assay

357

2524

1.47

9.91

25.0

21.1

inr

1.2

0.70

370

(3020961) Endomysium IgA Ab [Titer] in Serum

201

1253

1.65

9.76

1.1

titre

172.0

152.0

—

(36660697) Celiac disease serology panel - Serum

303

2078

1.51

9.76

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

716

5721

1.34

9.65

2.3

2.4

umol/l

1647.5

4629.5

2.71

615

5004

(3030467) Casts [#/volume] in Urine by Automated count

762

6147

1.33

9.61

3.0

e6/l

0.3

0.4

2.01

592

4588

(36304419) Bacteria [Presence] in Urine

749

6031

1.33

9.56

2.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

699

5581

1.34

9.44

4.1

3.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

241

1588

1.57

9.31

2.9

2.8

ng/l

141.9

174.7

0.97

222

1433

(3009508) Creatinine [Moles/volume] in Urine

818

6693

1.31

9.27

3.3

3.1

mmol/l

7.0

7.1

0.28

707

5652

(40768797) Stomach Pathology biopsy report

446

3339

1.40

9.02

1.2

—

(4062490)

242

2.43

8.97

1.6

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

332

2.20

8.86

1.4

1.6

—

(3026782) Osmolality of Urine

551

4288

1.35

8.75

2.6

2.7

mosm/kgh2o

516.2

534.3

0.88

463

3647

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

540

1.90

8.34

1.3

u/ml

1.0

3.7

0.96

(3009214) Lutropin [Units/volume] in Serum or Plasma

115

642

1.82

8.30

1.6

1.3

u/l

14.5

12.4

0.63

522

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

544

4267

1.34

8.15

1.7

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

324

2334

1.44

8.12

1.7

—

(3024731) MCV [Entitic volume]

2743

26707

1.92

8.08

25.0

18.9

90.5

90.8

2.44

2724

26370

(3007461) Platelets [#/volume] in Blood

2742

26695

1.91

8.07

25.1

18.9

e9/l

262.7

260.0

1.40

2701

26063

(3000963) Hemoglobin [Mass/volume] in Blood

2744

26722

1.93

8.05

25.2

19.0

g/l

133.6

133.7

0.16

2724

26380

(3005322) IgE [Units/volume] in Serum or Plasma

247

1690

1.51

8.04

1.4

1.3

u/ml

145.7

186.4

0.60

234

1560

(3035941) MCH [Entitic mass]

2743

26710

1.92

8.03

25.0

18.8

30.1

30.2

2.19

2724

26371

(3013512) EKG study

766

6312

1.29

8.03

3.9

3.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

120

686

1.78

8.02

1.4

1.3

u/ml

10.4

7.0

0.19

(3002385) Erythrocyte distribution width [Ratio]

2171

20273

1.31

8.00

19.5

15.5

13.6

0.42

2135

19839

(3026361) Erythrocytes [#/volume] in Blood

2743

26713

1.91

7.99

25.1

18.9

e12/l

4.5

0.34

2698

26017

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

695

1.77

7.96

1.4

1.3

u/ml

5.8

7.0

0.16

134

(3007853) Bacteria identified in Skin by Aerobe culture

363

2679

1.41

7.94

1.8

1.7

—

(3010813) Leukocytes [#/volume] in Blood

2743

26716

1.91

7.94

25.2

19.0

e9/l

6.7

6.6

0.11

2700

26011

(3024354) Oxygen [Partial pressure] in Venous blood

221

1481

1.53

7.93

3.6

3.0

kpa

4.4

4.6

1.48

215

1434

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

320

2316

1.43

7.81

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

480

3720

1.35

7.76

2.6

e6/l

1.0

1.4

1.11

288

2082

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2492

23793

1.40

7.58

5.2

4.6

mmol/l

2.9

2.8

0.84

2332

22082

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

129

767

1.71

7.54

1.6

iu/ml

0.0

0.4

0.90

146

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2446

23287

1.37

7.53

4.6

4.1

mmol/l

1.5

2.42

2283

21640

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

227

1550

1.51

7.47

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

620

5010

1.30

7.46

2.0

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

255

1790

1.47

7.32

4.0

3.7

kpa

5.8

0.03

250

1740

(3002032) Base excess in Venous blood by calculation

253

1774

1.47

7.30

4.1

3.7

mmol/l

2.1

1.9

0.28

221

1439

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2457

23432

1.37

7.28

4.7

4.2

mmol/l

4.8

0.28

2309

21880

(3035637) Corticotropin [Mass/volume] in Plasma

286

2.16

7.27

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2363

22407

1.33

7.24

4.2

3.7

mmol/l

1.3

0.03

2197

20709

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.34

7.24

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1807

16579

1.25

7.23

3.6

3.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

420

3228

1.35

7.14

2.0

2.1

29.7

29.3

0.44

406

3120

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.72

7.12

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

140

2.66

7.06

1.3

1.4

u/l

4.6

5.7

1.32

119

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

736

1.70

7.04

1.6

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

489

3852

1.33

7.04

1.7

nmol/l

1220.2

1196.2

0.23

382

2909

(3020682) Albumin/Creatinine [Ratio] in Urine

771

6448

1.27

7.02

4.1

3.9

mg/mmol

8.3

8.6

0.06

488

3902

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

360

2710

1.38

6.98

1.5

1.4

—

(3016502) Oxygen saturation in Arterial blood

272

1954

1.43

6.91

8.1

8.0

95.7

96.0

0.21

263

1895

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

725

1.70

6.90

2.1

2.4

g/l

9.9

10.2

0.44

101

624

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1742

15965

1.24

6.82

3.3

3.0

u/l

41.6

43.0

0.36

1645

14953

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

302

2222

1.40

6.71

2.2

2.3

u/l

44.8

39.5

0.18

254

1893

(3012516) Albumin [Mass/volume] in Urine

733

6122

1.27

6.71

3.5

3.2

mg/l

301.3

327.9

0.06

450

3666

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

186

1249

1.52

6.64

1.4

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

116

2.78

6.64

3.6

2.6

u/ml

734.9

954.6

0.68

116

(3002173) Hemoglobin [Mass/volume] in Arterial blood

256

1835

1.43

6.59

8.5

8.3

g/l

122.9

120.6

1.23

250

1774

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

143

907

1.61

6.56

3.4

2.7

1.3

1.2

0.50

143

900

(3008152) Bicarbonate [Moles/volume] in Arterial blood

181

1214

1.52

6.50

7.5

mmol/l

24.8

24.6

0.36

173

1138

(3041096) Erythrocytes [Presence] in Urine by Automated

769

6481

1.26

6.48

3.4

3.2

—

(3033658) Prothrombin time (PT) actual/Normal

693

5774

1.27

6.43

4.0

3.7

94.9

94.3

0.27

674

5608

(3021960) Folate [Moles/volume] in Serum or Plasma

616

5063

1.28

6.39

1.6

1.5

nmol/l

21.0

21.1

0.10

531

4327

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

123

757

1.65

6.37

1.4

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

253

1822

1.43

6.35

3.2

3.6

mmol/l

1.2

0.27

206

1581

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

337

1.98

6.32

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

791

1.63

6.28

2.2

2.4

g/l

7.3

7.5

0.29

599

(3017446) Testosterone [Moles/volume] in Serum or Plasma

136

863

1.61

6.24

2.5

2.0

nmol/l

9.2

10.8

1.30

122

758

(3039162) Centromere protein B Ab [Units/volume] in Serum

333

1.97

6.17

1.3

u/ml

42.9

50.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

111

671

1.68

6.16

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1267

11312

1.22

6.11

4.1

3.9

—

(40761535) Cells panel - Urine sediment

253

1836

1.42

6.09

3.8

3.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

790

1.62

6.08

2.2

2.4

g/l

3.6

3.7

1.16

569

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

791

1.62

6.05

2.2

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

706

1.66

6.03

1.3

1.1

—

(40768443) Skin Pathology biopsy report

150

985

1.55

5.96

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

233

1675

1.43

5.92

2.4

2.2

ug/l

6.9

6.5

0.07

203

1465

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

339

1.94

5.88

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

155

1029

1.54

5.87

1.8

1.6

mu/l

332.5

302.1

0.48

132

923

(3019060) Gas panel - Arterial blood

185

1275

1.48

5.86

4.8

5.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

100

597

1.70

5.83

2.8

3.5

mg/l

76.6

40.5

0.30

490

(3034860) Kappa light chains.free [Mass/volume] in Serum

100

597

1.70

5.83

2.8

3.5

mg/l

511.7

155.6

0.33

490

(3030981) Hyaline casts [#/volume] in Urine by Automated count

159

1064

1.52

5.80

2.7

e6/l

0.1

0.3

2.39

149

1032

(3004616) Nuclear Ab [Presence] in Serum

306

1.98

5.79

1.6

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

297

2234

1.37

5.78

2.4

2.5

1.7

1.8

1.68

263

1991

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

723

1.63

5.75

1.1

u/ml

0.8

4.7

2.24

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

444

1.80

5.69

1.6

1.4

u/l

30.8

27.8

0.29

372

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

132

852

1.58

5.67

1.7

1.8

g/l

1.5

0.07

110

742

(3013139) Helicobacter pylori Ag [Presence] in Stool

231

1673

1.41

5.63

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

343

2650

1.33

5.60

2.6

2.7

umol/l

5.2

7.1

3.83

282

2279

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

110

683

1.64

5.54

2.2

2.5

g/l

0.4

0.8

1.10

602

(40768804) Tissue Pathology biopsy report

1146

10214

1.21

5.42

2.1

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

431

3457

1.29

5.36

2.9

2.7

e6/l

3.7

3.6

0.04

245

1828

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

746

1.59

5.31

2.3

2.4

g/l

3.0

3.1

0.94

584

(3003396) Base excess in Arterial blood by calculation

294

2238

1.35

5.31

7.9

7.4

mmol/l

1.4

1.1

0.59

240

1742

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

207

2.14

5.29

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

207

2.14

5.29

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

101

623

1.64

5.24

2.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

208

2.13

5.23

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

169

1173

1.47

5.20

2.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

209

2.12

5.17

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

209

2.12

5.17

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

209

2.12

5.17

1.2

1.1

—

(4034850)

118

763

1.57

5.06

12.4

8.6

—

(3030313) Adrenal Ab [Titer] in Serum

4.80

5.01

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

239

1784

1.37

4.90

3.8

4.0

0.6

0.02

360

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

436

1.74

4.87

4.0

5.6

iu/ml

205.3

298.9

—

(3029075) Extractable nuclear Ab panel - Serum

2.93

4.87

1.1

—

(3000494) Fungus identified in Specimen by Culture

353

2794

1.30

4.85

1.5

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

392

1.78

4.85

1.3

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

257

1946

1.35

4.81

4.1

4.2

0.9

0.11

497

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

128

854

1.52

4.79

4.4

3.6

50.0

49.0

0.18

128

844

(3023323) Follitropin [Units/volume] in Serum or Plasma

207

1515

1.40

4.78

1.4

1.3

iu/l

29.5

0.00

170

1303

(3027801) Oxygen [Partial pressure] in Arterial blood

291

2247

1.33

4.78

8.0

7.4

kpa

12.6

12.8

0.19

281

2152

(3044640) Blood type and Crossmatch panel - Blood

860

7529

1.20

4.78

2.5

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

584

1.63

4.78

2.8

3.5

ratio

1.2

1.6

—

(3003338) MCHC [Mass/volume]

2174

20676

1.22

4.77

21.6

16.3

g/l

331.7

0.06

2164

20524

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

291

2248

1.33

4.77

8.0

7.4

kpa

5.0

5.1

0.70

281

2153

(3014007) Fractional oxyhemoglobin in Arterial blood

172

1227

1.43

4.61

10.0

8.6

93.9

94.1

0.09

172

1221

(3003327) Ova and parasites identified in Stool by Light microscopy

126

846

1.51

4.59

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

484

1.67

4.52

1.0

1.1

u/ml

3.0

5.1

1.05

254

(3037756) Immunofixation for Serum or Plasma

401

1.74

4.51

1.5

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

625

1.59

4.50

2.2

2.3

g/l

38.9

37.8

0.97

541

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.16

4.48

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

100

642

1.58

4.46

1.3

1.2

titre

1544.0

910.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

2.45

4.46

1.4

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.63

4.39

1.1

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

562

1.60

4.27

2.3

2.4

g/l

0.0

0.00

521

(3008401) Mugwort IgE Ab [Units/volume] in Serum

463

1.66

4.21

1.0

1.1

u/ml

0.3

1.0

1.66

197

(3008898) HLA-B27 [Presence]

139

972

1.45

4.17

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

465

1.65

4.14

2.7

2.5

ug/min

50.7

94.2

1.08

283

(40760888) Immunoglobulin light chains.free panel - Serum

442

1.67

4.14

2.8

3.7

—

(3036489) Thrombin time

127

874

1.47

4.14

2.1

21.4

21.2

0.06

117

745

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

609

1.56

4.07

2.3

g/l

0.0

0.89

565

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

376

1.72

4.06

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.57

4.05

1.1

1.0

—

(3000991) Gas panel - Venous blood

214

1620

1.35

4.05

9.1

8.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

2.16

4.02

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

2.08

4.01

2.1

2.0

—

(3022621) pH of Urine by Test strip

210

1588

1.35

4.00

2.6

2.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

102

676

1.53

3.99

2.1

2.3

ug/l

311.5

694.3

0.61

625

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

557

1.58

3.97

2.3

2.4

g/l

0.0

0.00

520

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.54

3.96

1.1

ng/l

20.0

332.9

—

(3015183) Erythrocyte sedimentation rate

150

2.15

3.96

1.5

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

719

6289

1.19

3.92

1.7

1.6

mmol/l

1.4

0.03

587

5354

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

144

1028

1.42

3.89

9.8

10.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

336

1.74

3.88

3.0

2.9

u/ml

273.6

1564.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

240

1861

1.32

3.86

4.1

4.2

0.1

0.2

1.11

459

(3025159) Blasts/100 leukocytes in Blood

229

1766

1.32

3.83

4.1

4.3

0.1

0.5

0.73

386

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

651

5654

1.20

3.83

2.5

2.2

—

(3017704) Immunofixation for Urine

101

2.39

3.81

1.7

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

509

1.59

3.76

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

288

1.78

3.73

1.2

1.3

nmol/l

—

(3020891) Body temperature

115

795

1.47

3.70

5.0

4.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

189

1.97

3.68

2.9

3.2

55.5

56.4

0.07

123

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

380

1.67

3.67

1.4

1.3

u/ml

5.5

4.9

0.11

153

(3023520) Reticulocytes [#/volume] in Blood

214

1646

1.32

3.66

2.3

2.6

e9/l

67.7

71.8

0.93

158

1240

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

593

1.53

3.65

3.6

3.2

u/ml

0.4

0.60

338

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

263

2082

1.29

3.64

2.1

2.3

g/l

0.2

0.38

254

1958

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

397

1.65

3.61

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.36

3.57

1.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

170

1268

1.36

3.57

2.7

2.1

u/l

3955.0

5219.3

0.23

512

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.51

3.54

2.0

2.1

138.3

156.5

0.59

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

213

1.89

3.54

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

225

1756

1.31

3.48

7.8

6.5

mmol/l

1.2

1.3

1.52

216

1689

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

188

1431

1.34

3.46

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

403

1.63

3.43

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.77

3.42

1.8

2.2

e6/l

256.0

158.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

396

1.63

3.40

1.4

1.2

u/ml

4.9

4.2

0.09

118

(44806118)

253

1.79

3.37

1.4

—

(44790047)

253

1.79

3.37

1.4

—

(44790048)

253

1.79

3.37

1.4

—

(44790049)

253

1.79

3.37

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

645

1.49

3.37

1.2

titre

75.0

83.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

452

1.59

3.37

1.1

u/ml

2.8

1.8

—

105

(3007930) Methemoglobin/Hemoglobin.total in Blood

113

800

1.43

3.25

4.5

6.2

0.9

0.41

105

753

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

177

1.93

3.24

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

340

1.66

3.22

1.3

nmol/l

—

0.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.17

3.21

1.0

1.2

—

(3025941) Bacteria identified in Stool by Culture

186

1433

1.32

3.18

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

548

1.51

3.16

1.1

u/ml

1.8

1.3

0.14

213

(3019225) pH of Specimen

276

2239

1.26

3.16

5.1

4.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

524

1.52

3.15

1.3

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

484

1.54

3.15

1.4

nmol/l

0.4

0.15

387

(4010399)

208

1633

1.30

3.10

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

105

742

1.43

3.07

2.0

ug/l

1.2

2.1

0.88

657

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.27

3.03

1.2

1.1

iu/ml

189.9

200.1

0.06

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

570

1.49

3.02

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

250

2017

1.26

3.00

4.1

3.8

—

(3022145) Colonoscopy Study observation

319

2646

1.23

3.00

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

596

1.47

2.99

1.5

1.3

mg/l

728.8

512.7

0.37

568

(3028707) Methadone [Presence] in Urine by Screen method

411

1.57

2.97

2.1

2.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

234

1.76

2.96

2.4

1.7

pmol/l

154.7

185.6

0.98

217

(3032773) Endomysium IgG Ab [Titer] in Serum

212

1.80

2.96

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

169

1.90

2.95

1.9

2.0

15.8

13.2

0.53

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.83

2.91

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

120

877

1.38

2.91

1.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

163

1.91

2.90

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

446

1.54

2.88

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

651

1.44

2.88

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

120

879

1.38

2.87

1.6

1.8

—

(3002256) Pathology report gross observation

367

3104

1.21

2.85

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

106

762

1.41

2.84

2.9

3.2

g/l

0.4

0.3

0.51

287

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

400

1.56

2.83

1.1

1.0

—

(4015189)

2.77

2.81

3.1

2.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

417

1.55

2.80

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

417

1.55

2.80

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

531

1.48

2.79

1.5

1.3

mmol/l

3.6

3.7

0.18

504

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

491

1.50

2.77

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

2.27

2.77

1.4

1.1

—

3.8

—

(3036603) Volume of Urine

159

1.90

2.75

1.3

1.4

1982.7

2019.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

1.83

2.73

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

135

1017

1.34

2.73

1.7

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

111

2.08

2.72

2.4

1.5

u/l

14.1

13.0

0.24

106

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

667

1.42

2.72

2.6

2.5

167.8

179.4

0.83

638

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

156

1203

1.31

2.69

1.6

1.7

—

(4268621)

257

1.68

2.67

2.4

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

311

1.62

2.67

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

520

1.47

2.67

4.0

4.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

224

1812

1.26

2.66

2.5

ml/min/173m2

69.2

68.5

0.09

699

(3000330) Specific gravity of Urine by Test strip

150

1153

1.32

2.65

3.0

3.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

122

912

1.35

2.61

1.4

1.3

miu/ml

214.0

217.4

0.04

467

(3039000) Anion gap in Blood

441

1.51

2.60

5.6

9.2

mmol/l

11.5

11.1

0.44

400

(3047181) Lactate [Moles/volume] in Blood

649

1.42

2.58

5.4

7.4

mmol/l

1.3

1.2

0.44

566

(3018572) Chloride [Moles/volume] in Blood

442

1.51

2.58

5.6

9.2

mmol/l

104.4

105.1

0.59

401

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

200

1.76

2.56

1.6

1.4

45.6

35.4

0.72

119

(3034274) Bile acid [Moles/volume] in Serum --fasting

403

1.52

2.54

2.2

umol/l

5.4

5.5

0.03

291

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

109

804

1.37

2.54

4.4

6.2

1.7

1.6

0.32

101

757

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.17

2.51

2.9

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

365

1.55

2.48

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

1.74

2.48

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

422

1.50

2.47

3.2

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

256

1.65

2.45

1.3

1.6

—

(3045414) Leukocytes [Presence] in Urine

147

1141

1.30

2.44

1.8

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

522

1.45

2.44

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

440

1.49

2.43

1.8

2.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

465

1.47

2.42

1.2

u/ml

322.2

267.6

0.37

278

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

523

1.45

2.42

1.4

e6/l

52.7

25.2

0.30

407

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

1.87

2.41

1.2

1.1

u/l

0.9

1.1

1.43

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.18

2.41

1.1

1.3

100.4

94.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.01

2.40

4.7

6.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

524

1.44

2.40

1.5

1.4

e6/l

2178.1

1439.9

0.14

431

(3004809) Band form neutrophils/100 leukocytes in Blood

321

1.57

2.38

2.7

3.3

1.1

1.4

0.67

251

(3009542) Hematocrit [Volume Fraction] of Blood

2288

22223

1.16

2.37

18.1

13.6

39.6

39.4

0.69

1687

16663

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

468

1.46

2.35

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

107

799

1.35

2.33

2.0

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

214

1.69

2.32

2.9

4.0

—

(4211845)

126

1.91

2.30

2.9

3.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

356

1.53

2.30

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

177

1.76

2.30

1.6

1.5

umol/l

10.7

11.4

0.27

166

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.38

2.29

1.1

1.4

34.9

48.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

521

1.43

2.28

1.4

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

170

1.77

2.28

1.1

1.2

titre

115.0

217.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

185

1.74

2.28

1.1

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

254

1.62

2.27

1.1

1.2

u/l

56.5

56.7

0.01

173

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.49

2.27

2.4

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

1.87

2.26

2.4

2.8

42.1

44.4

0.19

(3042936) Bacteria identified in Isolate by Culture

364

3147

1.18

2.24

2.2

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

194

1.71

2.22

1.4

1.2

mg/l

32.7

35.1

0.19

164

(3025468) Yersinia sp identified in Specimen by Organism specific culture

295

1.57

2.22

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.20

2.21

1.8

1.3

pmol/l

49.1

54.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

343

2956

1.18

2.20

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

296

1.56

2.19

1.5

1.4

—

(3003181) Sodium [Moles/volume] in Urine

369

1.50

2.18

1.2

1.4

mmol/l

61.8

62.2

0.03

303

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

297

1.56

2.16

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

297

1.56

2.16

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

196

1.69

2.15

1.1

nmol/l

397.9

391.1

0.07

174

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.29

2.15

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

647

1.37

2.14

2.5

2.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

122

944

1.31

2.11

4.4

4.0

mmol/l

24.3

24.1

0.30

113

848

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

259

2188

1.20

2.08

3.0

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.91

2.07

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

423

1.45

2.07

2.1

3.2

umol/l

32.2

34.9

0.56

363

(3042517) Benzodiazepines panel - Urine

3.51

2.05

4.1

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

425

1.44

2.02

1.4

u/ml

129.1

112.9

0.21

(3051387) C reactive protein [Mass/volume] in Capillary blood

492

1.41

2.02

4.2

3.5

mg/l

16.6

24.7

1.91

309

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

384

1.47

2.02

1.1

1.0

u/ml

1.3

2.8

1.59

181

(3044290) Cell count panel - Cerebral spinal fluid

485

1.41

1.99

1.6

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

240

1.59

1.98

1.6

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

148

1.76

1.98

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

304

1.52

1.98

1.5

1.4

—

(3011648) Oxygen content in Venous blood

156

1.74

1.96

2.2

2.3

10.9

0.01

156

(3017732) Neutrophils [#/volume] in Blood

204

1695

1.22

1.96

2.9

2.6

e9/l

4.1

0.01

160

1355

(3010144) Erythrocytes [#/volume] in Synovial fluid

202

1.64

1.95

1.3

1.4

e6/l

67065.7

102232.1

0.20

136

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

1.91

1.95

1.5

2.9

umol/l

113.5

195.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

149

1.75

1.94

1.0

—

(3011412) CD3 cells [#/volume] in Blood

218

1.61

1.94

2.0

2.3

e9/l

1.1

1.2

0.08

137

(3023430) Cat dander IgE Ab [Units/volume] in Serum

355

1.47

1.93

1.0

1.1

u/ml

19.4

4.7

0.35

137

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.25

1.90

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.25

1.90

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.25

1.90

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.25

1.90

1.3

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

227

1.59

1.90

3.3

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.01

1.90

1.1

99.8

90.7

—

(4027681)

151

1.73

1.87

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.40

1.85

1.5

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

587

1.36

1.84

1.9

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

1.83

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

198

1.62

1.83

1.1

1.2

u/ml

0.0

1.2

1.18

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

214

1.60

1.82

1.7

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.13

1.82

1.1

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

385

1.44

1.81

1.4

1.5

—

(4306422)

377

1.44

1.80

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

244

2081

1.19

1.80

2.2

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

2.58

1.80

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.05

1.80

1.4

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

428

1.41

1.79

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

428

1.41

1.79

1.2

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.76

1.79

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

513

1.37

1.78

1.8

1.7

e6/l

6951.9

10971.6

0.98

370

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

379

1.43

1.76

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.50

1.74

1.4

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

716

1.31

1.73

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

375

3323

1.15

1.71

2.2

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

114

905

1.27

1.68

1.8

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

148

1211

1.23

1.68

7.1

6.8

mmol/l

24.9

0.02

148

1205

(3024522) Salmonella sp identified in Specimen by Organism specific culture

301

1.47

1.65

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

335

1.44

1.63

1.1

1.2

—

(40768441) Liver Pathology biopsy report

181

1.61

1.63

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

158

1.65

1.62

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

166

1.63

1.61

1.0

1.1

u/ml

0.1

3.2

—

(1761868) Lipid panel - Serum or Plasma

926

8677

1.10

1.60

2.9

2.6

—

(3006462) Nitrate [Presence] in Urine

113

1.78

1.60

3.0

3.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.95

1.59

1.7

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

447

1.37

1.59

2.1

2.3

g/l

131.6

128.5

0.52

329

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

708

1.29

1.59

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

1.70

1.58

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.00

1.58

2.2

1.4

umol/l

64.8

43.1

—

(3028300) Cannabinoids [Presence] in Urine

114

914

1.26

1.57

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

397

1.39

1.57

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

153

1268

1.22

1.56

3.2

3.5

kpa

5.3

5.2

0.89

141

1177

(3022313) Gas panel - Capillary blood

114

915

1.26

1.56

3.2

3.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

160

1.63

1.55

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

390

1.39

1.54

1.1

u/ml

5.1

4.2

0.10

142

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

192

1.57

1.54

1.3

1.2

u/ml

22.5

40.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

192

1.57

1.54

4.5

3.4

—

(3027944) Amphetamines [Presence] in Urine

112

899

1.26

1.53

1.8

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

589

1.32

1.53

1.2

1.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

1.52

2.4

5.2

mg/l

18.8

18.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

124

1009

1.24

1.51

1.9

1.7

mg/l

3.4

3.7

0.18

701

(3027008) Opiates [Presence] in Urine

113

910

1.25

1.51

1.8

—

(3000492) Spirometry study

263

2295

1.16

1.50

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

242

1.49

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

284

1.45

1.47

1.4

pmol/l

327.6

310.4

0.12

225

(3014271) Vancomycin [Susceptibility]

1.81

1.47

3.5

2.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.23

1.46

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

664

1.29

1.46

1.4

ug/g

292.9

298.5

0.09

362

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

600

5528

1.11

1.45

1.5

—

(3019174) dRVVT (LA screen)

2.50

1.45

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.88

1.44

1.2

—

(3009343) pH of Capillary blood

150

1252

1.21

1.44

3.3

3.4

7.4

0.09

151

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

1.44

2.5

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

1.44

2.5

3.2

—

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.2

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

156

1.61

1.43

1.3

1.6

u/l

8.2

5.9

0.31

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

413

1.36

1.43

1.7

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

110

1.73

1.42

1.8

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

448

1.35

1.42

2.1

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

667

1.28

1.42

2.4

3.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

363

1.38

1.40

2.8

3.1

nmol/l

0.9

0.8

0.34

289

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

271

1.45

1.39

1.8

2.1

mg/l

18.8

25.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

144

1204

1.21

1.37

3.2

3.4

mmol/l

2.1

1.7

0.58

120

895

(42529406) Shigella sp [Presence] in Stool by Culture

724

1.27

1.37

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

135

1.63

1.35

1.1

1.3

—

645.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

159

1.58

1.34

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

280

2478

1.14

1.34

4.8

4.1

20.4

21.3

0.53

142

1134

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

419

1.34

1.32

1.5

1.4

ug/l

4.2

3.8

0.06

377

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

331

2966

1.13

1.31

1.7

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

196

1694

1.17

1.30

2.7

3.3

u/ml

57.4

52.0

0.10

188

1630

(3016879) Cocaine [Presence] in Urine

103

838

1.24

1.29

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

731

1.25

1.28

2.5

2.3

98.8

93.0

1.95

677

(3038177) Helicobacter pylori Ab [Presence] in Serum

439

1.33

1.28

1.3

1.2

—

(3034426) Prothrombin time (PT)

1.79

1.27

1.1

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

806

1.24

1.25

3.1

3.6

mmol/l

25.2

24.9

0.47

745

(3044927) Protein electrophoresis panel - Urine

203

1.48

1.24

1.1

1.2

—

(3000012) Reticulocyte production index

115

1.66

1.24

1.4

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

187

1.50

1.23

1.3

1.1

—

(4198724)

1.77

1.23

2.4

1.7

—

(3023419) Bacteria identified in Sputum by Culture

262

1.42

1.22

2.3

2.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

237

1.44

1.22

1.3

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.63

1.21

1.2

1.1

u/l

26.6

26.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.63

1.21

1.0

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.75

1.19

1.7

2.2

ug/l

2.1

1.0

0.73

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.31

1.18

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.11

1.18

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.50

1.15

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

326

1.36

1.14

1.0

u/ml

0.0

0.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

0.51

1.13

2.4

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.75

1.12

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.00

1.12

1.3

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

1.45

1.09

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

1.45

1.09

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

1.45

1.09

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.73

1.09

1.0

1.4

—

(4094501)

585

1.25

1.09

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.19

1.08

1.1

1.9

—

(4035726)

235

2091

1.14

1.08

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

461

1.29

1.07

2.2

4.0

kpa

9.0

8.7

0.62

456

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

470

1.28

1.07

1.7

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

1.93

1.06

1.3

mu/l

21.3

55.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

1.62

1.06

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

322

2924

1.11

1.05

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.12

1.05

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

288

1.36

1.05

1.2

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

195

1.44

1.04

1.2

2.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.74

1.02

2.5

1.6

ug/l

8.5

0.02

(21491868) Cryoglobulin [Mass/volume] in Serum

1.65

1.00

1.2

1.3

g/l

—

0.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.81

0.98

1.5

1.6

ug/l

0.4

—

(3017509) Phencyclidine [Presence] in Urine

2.18

0.98

1.8

1.1

—

(3012501) Base excess in Blood by calculation

460

1.27

0.96

2.2

4.0

mmol/l

1.9

2.6

1.44

314

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

1.54

0.96

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

469

1.26

0.96

1.4

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

461

1.26

0.95

2.2

4.0

kpa

4.9

5.1

0.94

456

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

141

1.49

0.94

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.89

0.94

1.0

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

277

1.34

0.93

2.1

1.6

57.9

57.3

0.03

171

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.92

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.82

0.92

1.1

umol/24h

0.5

0.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

134

1.50

0.91

1.6

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

0.91

1.0

—

(3010421) pH of Blood

563

1.23

0.91

2.3

3.9

7.4

0.12

455

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

296

1.32

0.91

1.1

g/l

1.6

1.5

0.36

261

(3015235) Bicarbonate [Moles/volume] in Capillary blood

492

1.25

0.90

4.0

3.0

mmol/l

25.8

24.9

0.73

430

(3044242) Glucose [Moles/volume] in Arterial blood

102

0.49

0.89

1.2

2.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.65

0.88

1.2

2.2

mg/l

6.5

10.2

2.82

(3017817) Protein [Mass] in Urine collected for unspecified duration

169

1.42

0.87

1.9

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.86

0.87

1.3

1.1

—

3.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

203

1.38

0.87

1.4

e6/l

2556.4

2574.2

0.01

142

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.72

0.86

5.4

4.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

1.49

0.82

1.0

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

1.49

0.82

1.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

1.49

0.82

1.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

1.49

0.82

1.0

1.6

—

(3021788) Differential panel - Synovial fluid

399

1.26

0.82

1.8

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

180

1.39

0.82

1.4

e6/l

58949.6

85501.5

0.21

100

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.88

0.81

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

118

1025

1.16

0.81

11.4

9.0

mmol/l

24.6

24.3

0.55

109

963

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

303

2787

1.10

0.81

1.7

1.3

1.4

1.21

271

2459

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

382

1.26

0.81

1.2

1.1

iu/ml

290.4

1475.8

0.40

(3004451) EKG impression Narrative

1.58

0.81

1.1

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.79

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

173

1.39

0.78

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

334

3092

1.09

0.78

5.4

4.7

ug/l

2.8

2.4

0.20

304

2765

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

247

2254

1.11

0.78

3.2

4.0

ug/l

15.0

24.8

0.48

190

1780

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.78

0.0

1.3

—

139.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.62

0.78

1.2

20.3

9.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

714

1.18

0.77

2.0

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

298

2749

1.09

0.76

7.2

6.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

175

1.37

0.74

1.8

2.2

u/field

1.9

2.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

158

1.40

0.74

2.2

2.6

e6/l

639.4

746.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.64

0.73

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

334

1.26

0.73

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

142

1.41

0.72

2.1

3.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.55

0.71

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.55

0.71

1.7

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

117

1.46

0.71

1.1

miu/ml

2294.8

1521.7

1.50

117

(3012441) Differential panel - Pleural fluid

169

1.36

0.69

1.3

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

382

1.23

0.69

1.2

1.7

—

(3011288) Drugs identified in Urine by Screen method

648

1.18

0.69

3.6

2.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

204

1.33

0.69

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.67

0.68

2.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.53

0.68

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.53

0.68

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.60

0.68

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

1.36

0.67

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.63

0.66

1.3

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.49

0.66

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

249

0.72

0.66

1.2

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.2

—

(21494755) Public health laboratory ask at order entry panel

226

2457

0.91

0.66

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

128

1.41

0.65

1.1

u/l

40.4

22.8

0.29

102

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

179

1629

1.11

0.63

2.0

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

757

1.15

0.63

2.7

3.5

u/ml

275.1

2048.1

0.73

646

(3042631) Mycobacterium sp identified in Specimen

252

1.27

0.62

3.1

2.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

191

1.31

0.61

1.5

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.59

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

157

1.34

0.59

1.9

1.4

u/ml

19.2

20.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

133

1198

1.12

0.58

1.6

1.4

—

(3025130) Human papilloma virus identified in Specimen

446

1.19

0.58

1.6

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.58

0.0

2.3

—

(3048879) Bone marrow aspiration report

1.51

0.58

1.4

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.72

0.57

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

1.42

0.57

1.6

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.48

0.57

2.6

3.5

mg/l

7.8

7.5

0.05

(3034891) Synovial lining cells/100 cells in Synovial fluid

115

1.39

0.56

2.1

1.3

1.9

4.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.57

0.56

3.6

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.51

0.56

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.51

0.56

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.62

0.55

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.45

0.55

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

177

1.30

0.54

1.3

1.8

mg/l

5.2

3.8

0.33

171

(44806071)

1.58

0.54

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.58

0.54

1.7

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

211

2276

0.92

0.54

1.8

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

159

0.69

0.54

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

125

1.36

0.53

1.6

1.7

u/field

2.3

3.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.54

0.53

2.0

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.35

0.53

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

232

1.25

0.52

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

206

1.26

0.51

1.1

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

324

1.21

0.51

1.7

1.8

mmol/l

1.5

1.7

1.34

319

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.47

0.50

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.46

0.50

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

343

1.20

0.50

1.3

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

362

1.19

0.49

1.3

1.4

mmol/l

6.2

7.2

1.53

254

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

110

1.37

0.48

1.6

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

0.65

0.48

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.52

0.48

1.9

2.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

172

1.28

0.48

1.2

1.1

ratio

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.48

1.3

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

128

1.33

0.47

1.1

u/l

125.8

78.7

0.49

105

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.49

0.47

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

173

1.27

0.46

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

283

1.20

0.45

1.4

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

320

1.19

0.44

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

1.22

0.44

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

239

1.22

0.42

1.3

1.6

mosm/kgh2o

282.8

278.8

0.54

188

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.42

1.1

—

(3017569) Oxygen content in Arterial blood

0.65

0.42

1.5

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.56

0.42

1.6

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

193

1806

1.07

0.41

3.3

2.9

ug/l

0.7

1.01

133

1151

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.41

0.0

1.1

—

22.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

268

1.20

0.40

1.2

—

(4281824)

315

0.82

0.40

1.1

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.6

—

3.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

1.30

0.40

1.3

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.4

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

250

1.20

0.40

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

418

1.15

0.39

2.5

15.8

16.3

0.33

205

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.31

0.39

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

607

1.12

0.39

1.8

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.39

1.4

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.41

0.39

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.39

0.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

242

1.20

0.38

1.7

1.6

mmol/l

6.9

7.7

0.82

142

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.39

0.38

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.35

0.38

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

726

0.89

0.37

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

161

1.24

0.37

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.39

0.37

1.0

—

(3045424) Erythrocytes [Presence] in Urine

422

1.14

0.36

1.5

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

744

0.90

0.36

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.33

0.35

2.2

2.9

—

(3005033) Fetal Nuchal fold Thickness US

722

0.90

0.35

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.37

0.34

1.3

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

227

1.19

0.34

1.2

1.7

—

(3020491) Glucose [Moles/volume] in Blood

182

1.21

0.33

1.7

1.6

mmol/l

6.3

6.7

0.28

127

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

568

1.11

0.33

2.2

3.7

mg/l

1.4

1.5

0.86

532

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

294

1.16

0.32

1.3

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.33

0.32

1.1

u/ml

11.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

101

1.29

0.31

1.0

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

101

1.29

0.31

1.0

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

156

1.22

0.31

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.30

0.30

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

212

1.18

0.30

4.0

5.8

mmol/l

7.2

7.0

0.10

175

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.33

0.30

1.1

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

102

1.28

0.30

1.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

0.77

0.29

1.3

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

449

1.12

0.29

3.3

3.0

kpa

8.2

8.4

0.39

416

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

167

1.20

0.28

2.0

1.7

—

(3028433) Virus identified in Specimen by Culture

1.32

0.28

1.0

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.29

0.28

3.9

4.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

289

1.14

0.28

2.4

2.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

168

1.19

0.27

3.0

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.21

0.26

1.0

1.4

—

(3020650) Glucose [Presence] in Urine

1.19

0.26

1.1

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

197

1.17

0.25

2.9

3.1

mg/l

10.7

32.5

1.50

134

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

169

1.18

0.25

1.2

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.25

0.25

1.2

1.1

—

(3024263) Appearance of Synovial fluid

105

1.24

0.24

2.0

1.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

880

0.93

0.24

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.28

0.24

2.2

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

879

0.93

0.24

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

879

0.93

0.24

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.71

0.24

1.7

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

124

1.21

0.24

1.3

1.4

nmol/l

164.4

133.1

0.89

124

(3000093) Morphology [Interpretation] in Blood Narrative

180

1.17

0.23

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

201

0.84

0.23

1.5

g/l

0.9

1.0

0.20

201

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.28

0.23

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.28

0.23

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.28

0.23

1.0

—

(3003694) ABO and Rh group [Type] in Blood

709

6957

1.03

0.22

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

876

0.93

0.22

1.4

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.4

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

262

0.88

0.21

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.23

0.21

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.5

—

21.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

0.82

0.20

1.2

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

335

1.11

0.20

1.8

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

0.00

0.20

0.0

1.7

—

59.3

—

(4212803)

0.00

0.20

0.0

1.0

—

(4024509)

231

1.13

0.19

1.7

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.18

0.19

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.76

0.17

1.4

2.8

—

(3044007) Cell count panel - Peritoneal fluid

0.72

0.17

1.4

2.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.10

0.15

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

1.21

0.15

8.5

9.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.15

0.15

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

1.15

0.15

1.9

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

472

0.93

0.15

3.4

3.6

56.9

57.1

0.04

472

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

120

1154

1.04

0.15

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.10

0.15

2.8

3.2

—

(21494434) Karyotype in Bone marrow

171

0.88

0.14

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.79

0.14

1.3

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.19

0.14

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

237

1.10

0.14

1.8

1.6

—

(3047189) Immunofixation for 24 hour Urine

0.82

0.13

1.1

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

171

1.11

0.12

1.9

1.5

promille

0.9

1.2

0.34

131

(1002224) Polysomnography panel

103

993

1.04

0.12

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

814

0.96

0.12

1.5

—

(40768806) Pleura Pathology biopsy report

181

1.11

0.12

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

116

0.86

0.12

1.3

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

116

0.86

0.12

1.3

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

126

0.87

0.11

1.6

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

328

1.07

0.11

4.8

5.3

umol/l

350.1

367.8

0.33

283

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

377

1.06

0.11

1.3

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.11

0.09

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.11

0.09

6.0

6.9

—

(3002619) Bacteria identified in Specimen by Culture

1.11

0.09

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

950

0.97

0.09

1.5

—

(44806420)

1.06

0.09

1.4

2.4

—

(3021901) Oxygen saturation in Capillary blood

340

1.06

0.09

3.9

2.7

—

(44813793)

184

1.09

0.09

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.11

0.09

2.0

1.3

—

(3024932) HLA-DR beta [Type]

1.09

0.08

1.0

1.1

—

(3024471) HLA-A [Type]

1.08

0.08

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

1.11

0.07

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

1.11

0.07

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

147

1.09

0.07

1.3

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

216

1.07

0.06

1.3

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.87

0.06

1.4

3.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

611

1.03

0.06

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

111

1089

1.02

0.05

1.4

1.5

—

(40768793) Breast Pathology biopsy report

733

1.02

0.05

1.2

1.3

—

(3035880) pH of Pleural fluid

1.10

0.04

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.10

0.04

1.0

—

4.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

854

1.02

0.04

2.5

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

285

2828

1.01

0.04

4.7

4.3

33.3

32.8

0.34

219

1926

(21494814) CD8 cells/100 lymphocytes in Specimen

1.09

0.03

2.1

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

165

1665

0.99

0.03

1.5

—

(1616796) Gas panel - Central venous blood

430

1.02

0.02

2.9

3.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

460

1.02

0.02

1.5

2.2

nmol/l

0.7

0.8

0.58

381

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

123

1.06

0.01

1.4

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

711

1.01

0.01

1.8

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

156

1550

1.01

0.01

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

135

1.04

0.00

1.6

1.9

—

9.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

195

1.03

0.00

1.4

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

255

0.98

0.00

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

241

1.00

0.00

2.2

3.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

138

1385

1.00

0.00

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

206

1.02

0.00

2.7

2.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

286

1.01

0.00

1.4

1.6

—

1680.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

158

1.01

0.00

1.2

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

172

0.99

0.00

2.0

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

167

1.02

0.00

1.4

1.2

—

(40768800) Prostate Pathology biopsy report

193

0.98

0.00

1.4

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

133

0.98

0.00

1.0

ng/l

1001.9

721.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.02

0.00

5.4

6.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.98

0.00

2.4

1.7

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

25.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

6.8

—

(4133840)

0.96

0.00

1.6

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(4146454)

240

1.00

0.00

2.6

2.8

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.93

0.00

1.0

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.89

0.00

1.6

1.4

35.4

29.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.97

0.00

1.0

1.1

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

4.4

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.87

0.00

1.3

1.7

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.00

0.00

36.3

31.3

ug/l

7.3

7.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.96

0.00

1.4

1.2

mg/l

0.4

97.9

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.3

—

(3007733) Chloride [Moles/volume] in Urine

0.00

0.0

1.3

—

79.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint THYROIDITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
THYROIDITIS	1.008 [0.89, 1.14]	0.906
Birth year	0.996 [0.99, 1.01]	0.422

During the follow-up period (1.1.1998 — 31.12.2019), 612 out of 10163 females with THYROIDITIS died.

Males

Parameter	HR [95% CI]	p-value
THYROIDITIS	0.815 [0.7, 0.94]	0.007
Birth year	0.99 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 242 out of 2542 males with THYROIDITIS died.

Mortality risk

Mortality risk for people of age

years, who have THYROIDITIS.

N-year risk	Females	Males
1	0.087%	0.169%
5	0.579%	1.044%
10	1.518%	2.768%
15	2.872%	5.227%
20	5.1%	8.575%

Relationships between endpoints

↥

Index endpoint: THYROIDITIS – Thyroiditis

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Thyroiditis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints